AIG
BIS icon

American International Group’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

American International Group’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-161
Closed -$37K – 4978
2015
Q2 		$37K Buy
161
+26
+19% +$6.45K ﹤0.01% 4173
2015
Q1 		$37.3K Buy
+135
New +$41.3K ﹤0.01% 4099

Other funds holding BIS

HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CAM
Chesapeake Asset Management New York $131M AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

American International Group's BIS Position: Q3 2015 in Review

American International Group sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2015, closing a stake of 161 shares — an estimated $37K sold.

American International Group first reported a position in BIS in Q1 2015 and held it in 2 quarters. The position peaked at $37.3K in Q1 2015. 19 funds tracked by Wall St. Rank hold BIS as of Q3 2015.

  • American International Group reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2015 after selling out during the quarter.
  • American International Group sold 161 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2015, an estimated $37K.
  • American International Group first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q1 2015 and held it in 2 quarters.
  • American International Group's ProShares UltraShort NASDAQ Biotechnology position peaked at $37.3K in Q1 2015.
  • 19 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2015.

Based on American International Group's 13F filing for Q3 2015, filed 12 Nov 2015.